Abstract

Atopic dermatitis, bronchial asthma, and food allergy are chronic diseases that can be associated with each other in childhood according to different trajectories.

Atopic dermatitis, bronchial asthma, and food allergy are chronic diseases that can be associated with each other in childhood according to different trajectories. The two main mechanisms that these diseases share are barrier damage and activation of immune cells that release type 2 inflammatory cytokines. Biological therapies can be beneficial in severe forms of these diseases, even in children. In atopic dermatitis, therapy with dupilumab is indicated from the age of 6 months. For asthma, the choice of the most appropriate biological drug must consider various aspects, including the patient’s age, features of the inflammation, and the presence of comorbidities and associated diseases.

Downloads

pdf
Authors

Ilaria Vella - Pediatric Unit, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy

Elena Monti - Pediatric Unit, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy

Mariano Di Rosa - Pediatric Unit, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy

Amelia Licari - Pediatric Unit, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy https://orcid.org/0000-0002-1773-6482

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright

Copyright (c) 2024 Italian Journal of Pediatric Allergy and Immunology

How to Cite
Vella, I., Monti, E., Di Rosa, M., & Licari, A. (2024). Type 2 Inflammation in Pediatrics: an overview. Italian Journal of Pediatric Allergy and Immunology, 38(3). https://doi.org/10.53151/2531-3916/2024-472
  • Abstract viewed - 122 times
  • pdf downloaded - 54 times